# Efficacy Study of Chinese Medicine Plus EGFR-TKI Versus EGFR-TKI in Advanced Pulmonary Adenocarcinoma

> **NCT01745302** · — · UNKNOWN · sponsor: **Shanghai University of Traditional Chinese Medicine** · enrollment: 470 (estimated)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** TCM
- **DRUG:** EGFR-TKI

## Key facts

- **NCT ID:** NCT01745302
- **Lead sponsor:** Shanghai University of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-11
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 470 (ESTIMATED)
- **Last updated:** 2016-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01745302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01745302, "Efficacy Study of Chinese Medicine Plus EGFR-TKI Versus EGFR-TKI in Advanced Pulmonary Adenocarcinoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01745302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*